Kiran Mazumdar Shaw, CEO of Biocon, discusses choices linked to the launching of a fresh cancer drug in India. Interviewed by Professor Sunil Gupta on May 6, 2009 at Harvard Business School.
PUBLICATION DATE: September 01, 2009 PRODUCT #: 510703-VID-ENG
This is just an excerpt. This case is about SALES & MARKETING